REG - Mast Energy Dvlpmts. - Exercise of Warrants, Issue of Equity & TVR

Mast Energy DevelopmentsAnnouncement

Tue 12:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250826:nRSZ7147Wa&default-theme=true

RNS Number : 7147W  Mast Energy Developments PLC  26 August 2025

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

LEI :213800HFVHGJ9YGO9F71

Share code on the LSE: MAST

ISIN: GB00BNG90H86

('MED' or 'the Company')

 

Dated: 26 August  2025

 

MAST Energy Developments PLC

("MED" or the "Company")

 

Exercise of Warrants, Issue of Equity & TVR

 

 

Mast Energy Developments PLC, the UK-based multi-asset owner, developer, and
operator in the rapidly growing Flexible Generation Power market, announces
that it has received notices of the exercise of Prepaid- and Cash Warrants,
issued pursuant to the Equity Fundraise announced on 11 July 2025, for a total
of 1,500,000 ordinary shares in the Company at a price of 4 pence per ordinary
share.

 

Application will be made for the admission of the 1,500,000 new ordinary
shares to trading on the LSE ("Admission") pursuant to the authorities
approved by shareholders at the General Meeting on 8 July 2025. The Shares
will rank pari passu with the existing ordinary shares and it is expected that
Admission will become effective at 8.00 a.m. on 28 August 2025.

 

Following Admission, the Company's issued share capital will consist of
14,748,927 ordinary shares with voting rights. MED  does not hold any
ordinary shares in treasury. This figure of 14,748,927 may be used by
shareholders in the Company as the denominator for the calculations by which
they will determine if they require to notify their interest in, or a change
to their interest in, the share capital of the Company under the UK Financial
Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Following Admission, the beneficial holding of Paul Venter, non-executive
director and chairman of the Company, will change from 14.79% to 13.28%
interest in the issued share capital of the Company. Further, following
Admission, the beneficial holding of Riverfort Global Opportunities PCC Ltd
will change from 12.87% to 11.56%.

 

Stay up to date with MED's latest news and updates by joining our emailing
list and social media channels, as follows:

 

MED general enquiries - https://www.med.energy/contact
(https://www.med.energy/contact)

MED email alerts - https://www.med.energy/rnsannoucements-1
(https://www.med.energy/rnsannoucements-1)

MED LinkedIn page
- https://uk.linkedin.com/company/mast-energy-developments-plc
(https://uk.linkedin.com/company/mast-energy-developments-plc)

MED X (formerly Twitter) handle - @mastplc

 

 

ENDS

 

This announcement contains inside information for the purposes of the UK
version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of
United Kingdom domestic law by virtue of the European Union (Withdrawal) Act
2018 ('UK MAR'). Upon the publication of this announcement, this inside
information is now considered to be in the public domain.

 

 Pieter Krügel      info@med.energy (mailto:info@med.energy)  Mast Energy           CEO

                                                              Developments PLC
 Guy Wheatley, CFA  +44 (0)74 9398 9014                       Fortified Securities  Corporate Broker
 Jon Belliss        +44 (0)20 7399 9425                       Novum Securities      Corporate Broker

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSEDFFMEISEEA